Insulin therapy is associated with worse outcome in patients with chronic heart failure and diabetes.


eMediNexus Editorial    29 March 2018

About one-third of patients with diabetes mellitus and heart failure (HF) are treated with insulin. However, since insulin causes sodium retention and hypoglycemia, its use might be associated with worse outcomes.

A new study published in the European Journal of Heart Failure proposed that other glucose-lowering treatments are probably safer than insulin therapy for patients with heart failure (HF) and type-2 diabetes mellitus.

The present study examined data from 24,012 patients with HF, from four large randomized trials, and an administrative database of 4 million individuals, 103,857 of whom had HF. The risk of hospitalization for HF was assessed in the former group. For the latter group, a case-control study within a population-based cohort study was conducted.

The results revealed that the prevalence of diabetes mellitus at baseline ranged from 25.5-29.5% across trials. Meanwhile, insulin alone or in combination with oral hypoglycemic drugs was prescribed at randomization to 24.4-34.5% of patients with diabetes. While, the rates of death from any cause and hospitalization for HF were higher in patients with diabetes than in those without; the highest rate being in patients who were prescribed insulin. Furthermore, insulin prescription was associated with a higher risk of all-cause death and re-hospitalization for HF.

In inference, it was stated that whether insulin use is associated with poor outcomes in HF should be investigated further with controlled trials.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.